Our aim is use the latest genetic techniques to accelerate and enhance traditional plant breeding and create new, non GM varieties of Artemisia with increased artemisinin yields.

Malaria claims almost a million lives every year but there is renewed global determination to halt it. The new varieties will improve the supply of artemisinin for use in artemisinin combination therapies (ACTs), making these vital medicines more accessible to malaria victims. They are being developed for use by farmers in Asia and Africa, for whom Artemisia can be an important source of income.